Overview
Slow-flow malformation, lymphatic type — also commonly known as lymphatic malformation (LM) or historically as cystic hygroma or lymphangioma — is a congenital vascular anomaly characterized by abnormal development of the lymphatic system. These malformations consist of dilated lymphatic channels and cysts that fail to connect properly to the normal lymphatic drainage system. They are classified as slow-flow vascular malformations, distinguishing them from high-flow lesions such as arteriovenous malformations. Lymphatic malformations most commonly affect the head and neck region (particularly the cervical area), axilla, mediastinum, and extremities, though they can occur in virtually any body site including the abdomen, retroperitoneum, and bones. They are typically present at birth or become apparent in early childhood. Clinically, they present as soft, compressible masses that may be macrocystic (large cysts), microcystic (small cysts), or mixed. Key symptoms include swelling, disfigurement, pain, and functional impairment depending on location. Complications can include infection (cellulitis or abscess), intralesional bleeding, compression of adjacent structures (such as the airway), and lymphatic fluid leakage. These malformations tend to grow proportionally with the child but may enlarge suddenly due to infection, trauma, or hormonal changes. Treatment is guided by the size, location, and type of lymphatic malformation. Macrocystic lesions often respond well to sclerotherapy, in which agents such as doxycycline, bleomycin, or OK-432 (picibanil) are injected directly into the cysts to induce shrinkage. Microcystic and mixed lesions are more challenging to treat and may require surgical excision, though complete removal is often difficult due to infiltration of surrounding tissues. Sirolimus (an mTOR inhibitor) has emerged as a promising medical therapy, particularly for extensive or refractory lymphatic malformations, and has shown efficacy in reducing lesion volume and symptoms. Multidisciplinary management involving vascular anomaly specialists, surgeons, interventional radiologists, and other specialists is recommended for optimal care.
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Slow-flow malformation, lymphatic type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Slow-flow malformation, lymphatic type at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Slow-flow malformation, lymphatic type.
Community
No community posts yet. Be the first to share your experience with Slow-flow malformation, lymphatic type.
Start the conversation →Latest news about Slow-flow malformation, lymphatic type
No recent news articles for Slow-flow malformation, lymphatic type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Slow-flow malformation, lymphatic type
What is Slow-flow malformation, lymphatic type?
Slow-flow malformation, lymphatic type — also commonly known as lymphatic malformation (LM) or historically as cystic hygroma or lymphangioma — is a congenital vascular anomaly characterized by abnormal development of the lymphatic system. These malformations consist of dilated lymphatic channels and cysts that fail to connect properly to the normal lymphatic drainage system. They are classified as slow-flow vascular malformations, distinguishing them from high-flow lesions such as arteriovenous malformations. Lymphatic malformations most commonly affect the head and neck region (particularly
How is Slow-flow malformation, lymphatic type inherited?
Slow-flow malformation, lymphatic type follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Slow-flow malformation, lymphatic type typically begin?
Typical onset of Slow-flow malformation, lymphatic type is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Slow-flow malformation, lymphatic type?
3 specialists and care centers treating Slow-flow malformation, lymphatic type are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.